Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

Clinical trial NCT02288741 · COMPLETED

Trial details

NCT number: NCT02288741
Sponsor: WiSP Wissenschaftlicher Service Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2001-08-01
Primary completion: 2012-09-01
Enrollment: 549

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.